NCT06413134
KPAP Adherence Crossover Study
At risk: Primary completion moved 12 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Dec 1, 2026 to Dec 1, 2027 Show 5 more changesShow less
- Start date: Jul 1, 2026 to Feb 1, 2027
- Eligibility criteria expanded, about 12 words
- Study completion pushed from Dec 31, 2026 to Dec 31, 2027
- Secondary endpoints: details revised at 5 of 5 entries
- Study description expanded, about 16 words
Notable Trial status: Withdrawn to Not Yet Recruitingv4 Show 9 more changesShow less
- Primary completion date: Aug 1, 2025 to Dec 1, 2026
- Start date: Dec 10, 2024 to Jul 1, 2026
- Enrollment target: 0 to 30
- Study completion date: Sep 1, 2025 to Dec 31, 2026
- Interventions: APAP (Device), TheraPAP (Device) to APAP (Device), KPAP (Device)
- Secondary endpoints: details revised at 5 of 5 entries
- Study description expanded, about 65 words
- Site contact updated
- Study title revised
- Stopped Trial status: Not Yet Recruiting to Withdrawn Sponsor's reason: This was supposed to be a pilot, single center study, which has been de-prioritized. A larger study will be conducted instead
- Enrollment target: estimated 32 to confirmed 0
- Site contact updated
- Notable Primary completion date: Dec 1, 2024 to Aug 1, 2025
- Start date: May 10, 2024 to Dec 10, 2024
- Study completion date: Jan 15, 2025 to Sep 1, 2025
- Secondary endpoints: details revised at 2 of 5 entries
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
Endpoints
Primary
Usage
Timeframe: Averaged over every night for each 4-week arm
Secondary (5)
ESS Questionnaire
FOSQ-10 Questionnaire
Excess Leak or Leak
P95/P90
AHI
Arms and interventions
4-weeks breathing on APAPPlacebo comparator
Patients will breathe on APAP for 4 weeks simulating normal therapy. Usage, leak, P95/P90 and AHI will be recorded and averaged over the duration.
4-weeks breathing on KPAPExperimental
Patients will breathe on TheraPAP for 4 weeks, which is the therapy under evaluation. Usage, leak, P95/P90 and AHI will also be recorded and averaged over the duration.
Devices: KPAP, APAP
Sites
1 site in 1 country
- Sleep Centers of Middle TennesseeMurfreesboro, Tennessee, United States